Skip to main content
Premium Trial:

Request an Annual Quote

No Place To Hide

When Pfizer bought Wyeth last year, the company said that it expected to cut about 15 percent of its workforce. However, on Friday, Pfizer said in a filing with the US Securities and Exchange Commission that the company will likely exceed that percentage, reports the Wall Street Journal. "At this point, it's too early to determine the extent to which we will exceed this target," says Joan Campion, a company spokesperson. The Journal adds that Pfizer appears to have nearly reached its original goal of a 15 percent reduction, noting that in January 2009 Pfizer and Wyeth had a combined 129,500 employees, and as of October there were only 111,500, "implying that 18,000 jobs have already been cut from January 2009 levels, or a nearly 14 percent reduction."

HT: Pharmalot

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.